Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | Director | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,478 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Purchase · Acquired 1,000 · Balance 41,478 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 30, 2026 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 1,000 | $6.00 | $6,000.00 |
DisclosureSEC source: 0001628280-26-063980 · wk-form4_1790799323.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,478 Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 11:38 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 20,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041043 · wk-form4_1780659497.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,979 Underlying: Common Stock · 20,979 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:31 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037537 · wk-form4_1779449461.xml · derivative · entry 2 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 11:31 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 21,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-037537 · wk-form4_1779449461.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 12:01 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 2,700 | $4.70 | $12,690.00 |
DisclosureSEC source: 0001628280-25-057483 · wk-form4_1765972865.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,478 Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 11:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | PurchaseCommon Stock | 2,700 | $4.97 | $13,419.00 |
DisclosureSEC source: 0001628280-25-043156 · wk-form4_1759230011.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,778 Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081726 · ownership.xml · derivative · entry 3 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F4 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081726 · ownership.xml · derivative · entry 2 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 27, 2025 Filed Jun 4, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 9,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081726 · ownership.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on May 27, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 9,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-069940 · ownership.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,826 Underlying: Common Stock · 9,826 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 4,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-054579 · ownership.xml · derivative · entry 2 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. F4 · derivative.expiration_date: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024. Read SEC document |
| May 04, 2024 Filed May 7, 2024 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 4,202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-054579 · ownership.xml · nonDerivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027927 · doc4.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 11:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 156,951 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-22-028447 · doc4.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,951 Underlying: Common Stock · 156,951 shares Expires 2032-05-09 F1 · derivative.exercise_date: The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:31 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantStock Option (Right to Buy) · Derivative | 63,325 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0001209191-21-026660 · doc4.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,325 Underlying: Common Stock · 63,325 shares Expires 2031-04-11 F1 · derivative.exercise_date: The option vests in 36 substantially equal monthly installments following April 12, 2021, such that the option shall be fully vested on April 12, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.